Abstract Objectives: To assess sleep pattern changes in patients with connective tissue diseases.
Introduction
Connective tissue disorders (CTDs) are defined as a group of acquired diseases resulting from persistent immune mediated inflammation. In most CTDs there is immune dysregulation resulting in generation of autoreactive T cells or autoantibodies [1] .
Sleep abnormalities have been recognized in a number of different rheumatic diseases, including rheumatoid arthritis, osteoarthritis, fibromyalgia, juvenile idiopathic arthritis, Sjo¨g-ren's syndrome, systemic lupus erythematosus, scleroderma, spondyloarthritis, sarcoidosis and Behcet's syndrome [2] .
Obstructive sleep apnea is a common disorder, characterized by recurrent narrowing and closure of the upper airway accompanied by intermittent oxyhemoglobin desaturation and sympathetic activation [3] . The presence of sleep apnea as a comorbidity may interfere with the evaluation of rheumatic disease activity and responsiveness to therapy [4] .
Aim of the work
The aim of our study is to assess sleep pattern changes in patients with connective tissue diseases.
Patients and methods

Thirty patients diagnosed as CTDs attending to outpatient
Immunology and Rheumatology clinic of Internal Medicine Department and outpatient clinic of Rheumatology Department of Menoufia University Hospital, and 30 apparent healthy control subjects were invited to participate in the study.
This study included 60 subjects; they were divided into two groups:
Group 1: consists of 30 patients who were diagnosed as CTD patients and on a regular medication regimen for CTD.
Group 2: consists of 30 apparent healthy subjects. Complete medical history was obtained; they were clinically free from any known CTDs.
Health Research Ethics Board of Menoufia University approved the study. Informed consent was obtained from all participants, each patient underwent:
It was conducted in the sleep laboratory unit, Chest Department, Menoufia University Hospital over a whole night (8 h sleep). We started the study at 10 P.M. until 6 A.M. using EMBLA S 4000 system (Iceland).
The PSG consisted of Somnologica studio software, electroencephalography sensor with its cables, electrooculography electrodes, electromyography electrodes for the chin and anterior tibialis muscle, Nasal canula and nasal thermistor, Thoracic and abdominal belt, Pulse oximetry sensor, electrocardiography electrodes with their cables, Snoring microphone, and Body position sensor (see Graph 5) .
Data obtained from this study were:
-Apnea index (AI): Complete cessation of airflow breathing at the nostrils and mouth for at least 10 s or longer. -Hypopnea index (HI): A decrease in rate and depth of breathing by 50% for 10 s or longer.
-Apnea-hypopnea index (AHI): Average number of apnea and hypopnea per hour of sleep. Persons with an AHI < 5 are not considered to have OSA. In contrast, an AHI P 5 and < 15, AHI P 15 and < 30, and an AHI P 30 are classified as mild, moderate, and severe respectively [7] . Table 2 shows a statistical significant difference between all patients & control group as regard Epworth sleepiness scale (ESS) and significant difference between them as regard Neck circumference and smoking. Table 3 displays Polysomnography parameters across the studied groups that shows:
Results
Total sleep time (TST), Sleep efficiency, REM Latency from Sleep Onset, Spontaneous Arousals Index, PLMS sequences, AHI, Oxygen Desaturation Events (OD), percentage of Snoring Time in TST, and Total AHI in NREM were significantly different in the cases compared with control group. There were no significant differences in Sleep Onset, flow limitation index,% of sleep in supine position, A + H/h in supine position, Average Oxygen Saturation, (%) of Lowest Oxygen Saturation, % of REM in TST, and Total AHI in REM across two groups. Table 4 shows Sleep disorders by AHI, cases were subdivided according to results of polysomnography into:
Mild OSA (AHI P 5 and <15): consisted of 4/30(13.3%) patients, moderate OSA (AHI P 15 and <30): consisted of 3/30(10%) patients, severe OSA (AHI P 30): consisted of 11/30(36.7%) patients, negative (AHI < 5): consisted of 12/30(40%) patients without OSA. Table 5 shows a significant positive correlation between AHI in patients and age, uric acid, and creatinine. In addition, there were highly significant positive correlations between AHI in patients and BMI, Neck circumference, ESS, ESR, CRP, and HCT. Table 6 shows a significant positive correlation between OD in patients and age and Neck circumference. In addition, there were highly significant positive correlations between OD in patients and BMI, ESS, ESR, CRP, and HCT. Table 7 shows the binary logistic regression model for risk factors of sleep related breathing disorders (SRBD), which demonstrates that ESR is independent risk factors for, SRBD with odds ratio 1.90 and CI (1.01-4.55).
Discussion
Sleep disorders have been described in more than 75% of subjects suffering from various forms of rheumatic diseases [8] . Co-existence of sleep apnea in rheumatic disease patients may influence the severity of reported symptoms of pain and fatigue, accelerate the risk of cardiovascular events and possibly influence levels of circulating inflammatory markers and mediators [4] . In the current work, the prevalence of Sleep apnea in CTDs was 18/30(60%). Sleep apnea was obstructive. Mean AHI was 23.42 ± 26.27/h. Among these OSA patients, (36.7%) had severe OSA (AHI > 30/h), (10%) had moderate OSA (AHI 15-30/h), (36.7%) had mild OSA (AHI 5-15/h).
In this study, OSA was diagnosed in 9/12(75%) of RA patients, 5/12(42%) of SLE patients, 4/5(80%) of Behcet's disease and 0/1(0%) of ankylosing spondylitis. The current study results agree with those of study done by Iaboni et al. [9] , which studied PSG recordings in SLE patients with disabling fatigue. Of the 35 patients studied, 26% met criteria for sleep apnea. This finding was in harmony with our result. Palagini et al. [10] showed that the prevalence of OSA in the SLE patients has ranged from 26-50%, which is considerably higher than the general healthy persons. These findings were in harmony with our results.
In the present work there were highly significant positive correlations between AHI in patients and BMI (r = 0.68, P < 0.001), Neck circumference (r = 0.65, P < 0.001), ESS (r = 0.79, P < 0.001), ESR (r = 0.74, P < 0.001), CRP (r = 0.73, P < 0.001), and HCT (r = 0.72, P < 0.001) ( Table 5) .
It is of interest that we recorded higher levels of CRP in CTD patients with OSA. In consistent with our study, Fouda and Abdel Dayem [11] have demonstrated increased CRP values among OSA patients.
In accordance with our results, Yousef and Alkhiary [12] reported that OSAS patients had a significantly higher oxygen desaturation index, Epworth sleepiness scale and significantly lower minimal, basal oxygen saturation, sleep efficiency and rapid eye movement sleep when compared to control subjects. In addition, hematocrit was significantly higher in OSAS.
Our study also confirmed previous findings of Valencia et al. [13] that sleep apnea, periodic limb movements (PLMS), a poor sleep pattern (higher percentage of wake stage, increased number of awakenings, and decreased sleep efficiency) are common sleep disorders in patients with CTDs, also Hypersomnolence was common in our CTD patients, and can be objectively associated with total sleep time of oxygen desaturation and sleep fragmentation.
Lessened sleep efficiency was a recorded polysomnographic finding among patients, as the mean value of sleep efficiency was (56.63 ± 29.26). In consistent with our study, several works have demonstrated decreased sleep efficiency among patients with ankylosing spondylitis and SLE [14, 15, 9] .
In the present work there were significant positive correlations between OD in patients and age (r = 0.38, P = 0.04) and Neck circumference (r = 0.43, P = 0.02). In addition, there were highly significant positive correlations between OD in patients and BMI (r = 0.57, P = 0.001), ESS (r = 0.60, P = 0.001), ESR (r = 0.57, P = 0.001), CRP (r = 0.68, P < 0.001), and HCT (r = 0.78, P < 0.001).
Our results agree well with an earlier study by Peppard et al. [16] that found BMI is an important predictor of the severity of OD during apneic and hypopneic events of sleepdisordered breathing, independent of age, gender, sleeping position, smoking history, baseline Sa O 2 , and event duration. Serum creatinine in OSA patients was significantly higher than controls (1.42 ± 0.50). Serum creatinine correlated significantly with AHI (P = 0.03). This is in agreement with the study of Bu¨chner et al. [17] who recorded that Serum creatinine correlated significantly with AHI.
Similar to our findings, Ruiz et al. [18] found a significant correlation between uric acid levels and some sleep parameters (number of respiratory events, number of desaturations, or the cumulative percentage of time with oxygen saturation less than 90%). Additionally, they showed that those patients with severe OSAS (AHI P 30) had higher uric acid levels than those with mild or no OSAS.
Conclusion
In conclusion, OSA is commonly associated with patients with CTDs. These findings possibly suggest common underlying pathological mechanisms, which may be linked to chronic inflammation. Co-existence of OSA in CTD patients may influence the disease activity and the level of circulating inflammatory markers in these patients. Considering diagnosis and treatment of this sleep disorder in CTD patients may help improve clinical care, better prognosis and avoid rheumatoidassociated morbidities.
